Progress, and Applications
of the Human Genome Project
Sponsored by the U.S. Department of Energy Human Genome Program
Human Genome News Archive Edition
Human Genome News, November 1993: 5(4)
On November 4, the Committee on Assessing Genetic Risks of the Institute of Medicine (IOM) of the National Academy of Sciences released its report on a study of a variety of issues raised by the rapid proliferation of genetic tests. Designed to produce policy options on urgent issues, the report was commissioned in 1990 as one of several proactive initiatives of the NIH-DOE ELSI component of the U.S. Human Genome Project. The 24-month study, cosponsored by the L. Markey Trust and chaired by Arno Motulsky (University of Washington, Seattle), was carried out by a panel of experts in human genetics, law, health education, economics, ethics, medicine, insurance, psychology, and regulation. Jane Fullarton (now at Tascon) was staff director of the project.
In the report, the committee attempted to set down broad guidelines and policy principles to guide the development and use of genetic tests. They pointed out that genetic testing is already used or may be used in newborn screening, prenatal testing, genetic carrier testing, medical diagnosis, and presymptomatic or predictive testing. Predictive testing, which is likely to have major impact, raises new problems because of the ability to identify individuals at risk long before they develop symptoms. The committee expressed concern about commercial pressures urging premature introduction of presymptomatic tests and recommended that pilot studies be carried out before certain types of tests are used routinely.
The committee recommended that genetic testing should be voluntary and that the individual should decide what to do with the genetic information, all forms of which should be confidential and not disclosed without the person's consent. All organizations that generate or maintain genetic information or samples should have established procedures for protecting confidentiality.
The committee strongly supported nondirective counseling and felt that appropriate medical options should be given only after a full discussion of the medical and social consequences of genetic information, including its possible impact on employment and health insurance. The panel also favored legislation to prohibit possible discrimination in health insurance and employment. Specific recommendations covered a wide variety of circumstances, including the following:
Prepublication copies of the report Assessing Genetic Risks: Implications for Health and Social Policy are available from the National Academy Press at 2101 Counstitution Avenue, NW; Washington, DC 20418 (202/334-3313 or 800/624-6242).
Return to the Table of Contents
Back to Home Page
The electronic form of the newsletter may be cited in the following style:
Human Genome Program, U.S. Department of Energy, Human Genome News (v5n4).
Last modified: Wednesday, October 29, 2003
Home * Contacts * Disclaimer
Document Use and Credits
Publications and webpages on this site were created by the U.S. Department of Energy Genome Program's Biological and Environmental Research Information System (BERIS). Permission to use these documents is not needed, but please credit the U.S. Department of Energy Genome Programs and provide the website http://genomics.energy.gov. All other materials were provided by third parties and not created by the U.S. Department of Energy. You must contact the person listed in the citation before using those documents.
Base URL: www.ornl.gov/hgmis
Site sponsored by the U.S. Department of Energy Office of Science, Office of Biological and Environmental Research, Human Genome Program